OverviewChartProfileKey statisticsFinancialsTechnicalNewsTraderScreen

Prothena Corporation PLC/  IE00B91XRN20  /

NASDAQ
31/05/2024  19:32:57 Chg. +0.5400 Volume Bid19:34:19 Ask19:34:19 Market Capitalization Dividend Y. P/E Ratio
20.7500USD +2.67% 184,949
Turnover: 2.63 mill.		 20.6800Bid Size: 100 20.7500Ask Size: 400 846.6 mill.USD 0.00% -
GlobeNewswire 28/03/2022 Prothena Announces FDA Clearance of IND for PRX012, a Subcutaneous Anti-Amyloid Beta Antibody Under ...
GlobeNewswire 21/03/2022 Prothena to Participate in Stifel 2022 Virtual CNS Days
GlobeNewswire 16/03/2022 Prothena Presents New Data for Alzheimer’s and Parkinson’s Disease Programs at AD/PD 2022
GlobeNewswire 17/02/2022 Prothena Reports Fourth Quarter and Full Year 2021 Financial Results, and Provides Financial Guidanc...
GlobeNewswire 10/02/2022 Prothena to Report Fourth Quarter and Full Year 2021 Financial Results and Host Webcast Conference C...
GlobeNewswire 29/11/2021 Prothena to Participate in JMP Securities Hematology and Oncology Summit
GlobeNewswire 04/11/2021 Prothena Reports Third Quarter 2021 Financial Results and Business Highlights
GlobeNewswire 28/10/2021 Prothena to Report Third Quarter 2021 Financial Results on November 4th
GlobeNewswire 01/10/2021 Prothena Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire 01/10/2021 Prothena Announces Executive Appointments
GlobeNewswire 03/09/2021 Prothena Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire 01/09/2021 Prothena to Participate in Upcoming September Healthcare Conferences
GlobeNewswire 05/08/2021 Prothena Reports Second Quarter 2021 Financial Results and Business Highlights
GlobeNewswire 29/07/2021 Prothena to Report Second Quarter 2021 Financial Results on August 5th
GlobeNewswire 26/07/2021 Prothena Presents New Data from Robust Alzheimer’s Portfolio at the Alzheimer’s Association Internat...
GlobeNewswire 20/07/2021 Prothena to Present Data from Two of its Alzheimer’s Disease Programs at the Alzheimer’s Association...
TeleTrader 12/07/2021 Novo Nordisk buys Prothena's heart therapy drug
GlobeNewswire 12/07/2021 Prothena and Novo Nordisk Announce Acquisition Agreement for Prothena’s ATTR Amyloidosis Programme
GlobeNewswire 24/06/2021 Prothena Announces Bristol Myers Squibb Opt-in of Anti-Tau PRX005 as the First Program from Global N...
GlobeNewswire 10/06/2021 Prothena to Participate in JMP Securities Life Sciences Conference on June 16
GlobeNewswire 20/05/2021 Prothena Announces Appointment of Sanjiv Patel, MBBS, to its Board of Directors
GlobeNewswire 11/05/2021 Prothena Reports First Quarter 2021 Financial Results and Provides Updated Financial Guidance and R&...
GlobeNewswire 10/05/2021 Prothena Announces Achievement of $60 Million Milestone From Roche for First Patient Dosed in Phase ...
GlobeNewswire 07/05/2021 Prothena Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire 04/05/2021 Prothena to Report First Quarter 2021 Financial Results on May 11th